CompletedPhase 4NCT03379974
Exercise Versus DDAVP in Patients With Mild Hemophilia A
Studying Mild hemophilia A
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nationwide Children's Hospital
- Principal Investigator
- Riten Kumar, MD, MSc, MBBS, MScNationwide Children's Hospital
- Intervention
- DDAVP Inhalant Product(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 13-21 years · MALE
- Timeline
- 2018 – 2019
Study locations (4)
- Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, United States
- Akron Children's Hospital, Akron, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Dayton Children's Hospital, Dayton, Ohio, United States
Collaborators
The Hospital for Sick Children
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03379974 on ClinicalTrials.gov